MYX Ann: Mayne Pharma to restate US dermatology net revenue for FY22 - 15th Feb 2023, 8:10am

annb0t

annb0t

Top 20
MYX Ann: Mayne Pharma to restate US dermatology net revenue for FY22
Price Sensitive: Y
Date: 15th Feb 2023, 8:10am

>>> Read announcement: Google: MYX Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
MYX Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook - 18th Oct 2023, 9:14am
Replies
0
Views
92
annb0t
annb0t
annb0t
MYX Ann: Mayne Pharma closes transaction for Rhofade - 26th Sep 2023, 8:22am
Replies
0
Views
68
annb0t
annb0t
annb0t
MYX Ann: Mayne Pharma presentation at HC Wainwright Conference in NY - 11th Sep 2023, 5:08pm
Replies
0
Views
78
annb0t
annb0t
annb0t
MYX Ann: Mayne Pharma to present at HC Wainwright conference in NY - 7th Sep 2023, 9:41am
Replies
0
Views
98
annb0t
annb0t
annb0t
MYX Ann: Mayne Pharma executes asset purchase agreement for Rhofade - 4th Sep 2023, 8:24am
Replies
0
Views
81
annb0t
annb0t
Top Bottom